We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tools for Genomics Research

By Biotechdaily staff writers
Posted on 13 Jul 2004
A new microarray tool for genomic research is expected to allow high resolution, sensitive, and reproducible detection of chromosomal abnormalities.

Spectral Genomics Inc. More...
(Houston, TX, USA; www.spectralgenomics.com) uses a proprietary method for producing genomic DNA microarrays that are designed to facilitate the genome-wide analysis of samples from which chromosome preparations are difficult or impossible. Spectral Genomics makes arrays from BAC (bacterial artificial chromosomes) clones. A BAC is a cloning vector derived from the Escherichia coli fertility plasmid, the F-factor. BACs can be used in the cloning of large DNA fragments, on average approximately 200 kb long, and are ideal as cloning vectors for the sequencing of whole genomes.

The new "Constitutional Chip” also includes spots representing negative controls, calibration controls for standardization of detection, and clones not likely to be affected by genetic defects that form the base line for detection. The "Constitutional Chip” is complemented by "SpectralWare,” web-based software that displays chromosomal abnormalities and their loci within the genome as interpreted from images produced by microarray scanners.

Dr. Ed Chait, CEO of Spectral Genomics, said, "It is particularly exciting to see the Spectral team introducing this major innovation in cytogenetics for which we have applied for a patent, allowing our customers and collaborators to experience the superior data that can be obtained from BAC clone microarrays.”




Related Links:
Spectral Genomics Inc.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Urine Analyzer
respons® UDS100
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.